VitaNova Life Sciences (VNOV) EBIT Growth (5y) (2022 - 2026)
VitaNova Life Sciences (VNOV) EBIT Growth (5y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Mckesson | 105.15 Bn | 101.18 Bn | 4.04 Bn |
| 2 | Cencora | 60.58 Bn | 58.40 Bn | 3.59 Bn |
| 3 | Cardinal Health | 53.81 Bn | 49.87 Bn | 2.50 Bn |
| 4 | Henry Schein | 9.71 Bn | 9.57 Bn | 1.07 Bn |
| 5 | Akso Health | 3.28 Bn | 3.28 Bn | - |
| 6 | 111 | 651.73 Mn | 572.63 Mn | 23.58 Mn |
| 7 | Accendra Health | 248.02 Mn | -88.86 Mn | 278.03 Mn |
| 8 | Edap Tms | 230.14 Mn | 215.14 Mn | 8.15 Mn |
| 9 | VitaNova Life Sciences | 11.51 Mn | 11.01 Mn | 316,343.00 |
| 10 | Cosmos Health | 9.57 Mn | 7.41 Mn | 1.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 78.50% |
| Oct 31, 2025 | 58.51% |
| Jul 31, 2025 | -23.60% |
| Apr 30, 2025 | 112.27% |
| Jan 31, 2025 | 79.26% |
| Oct 31, 2024 | 39.10% |
| Jul 31, 2024 | -17.96% |
| Apr 30, 2024 | 80.41% |
| Jan 31, 2024 | 16.67% |
| Oct 31, 2023 | -1.67% |
| Jul 31, 2023 | -8.91% |
| Oct 31, 2022 | -22.06% |
| Jul 31, 2022 | -36.96% |